These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4383297)

  • 1. [Topical aspects and new therapeutic possibilities in coronary heart disease].
    Krüger K; Felder K
    Med Welt; 1966 Jul; 29():1541-50. PubMed ID: 4383297
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of potassium magnesium asparagine on coronary disease and its complications].
    Lewandowicz J
    Pol Arch Med Wewn; 1967; 39(6):849-57. PubMed ID: 4385061
    [No Abstract]   [Full Text] [Related]  

  • 3. [New therapeutic possibilities in the field of coronary disease].
    Pretolani E; Coccheri S; Zoli I; Baroncini S; Donato S; De Rosa V
    Clin Ter; 1975 Feb; 72(3):225-53. PubMed ID: 1132215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on the therapeutic effect of potassium-magnesium aspartate in coronary disease].
    Szulc EJ
    Wiad Lek; 1968 Sep; 21(17):1509-14. PubMed ID: 4882478
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electrolyte therapy of coronary insufficiency in the practice].
    Menzel M
    Landarzt; 1968 Jul; 44(20):993-5. PubMed ID: 5717732
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction].
    Jiang XR; Chen WP; Shi HL; Zhou LF
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):36-9. PubMed ID: 6232818
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial electrolyte derangement: crucial feature of pluricausal, so-called coronary, heart disease (dysionic cardiopathy).
    Raab W
    Ann N Y Acad Sci; 1969 Jul; 147(17):627-86. PubMed ID: 4902584
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of curantyl in combination with potassium-containing preparations in chronic ischemic heart disease].
    Vasilevskiĭ VV; Neĭko EM; Debenko MV
    Klin Med (Mosk); 1976 Feb; 54(2):40-2. PubMed ID: 1271716
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protection for the ischemic myocardium: a transition between the experimental laboratory and medical practice].
    da Luz PL; Leite JJ; de Barros LF; Pileggi F
    Arq Bras Cardiol; 1980 Mar; 34(3):237-52. PubMed ID: 6108100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Objective evaluation of the therapeutic activity of iproveratril].
    Cherchi A; Raffo M; Bina M; Fonzo R; Maxia G; Esu MP
    Minerva Cardioangiol; 1971 Mar; 19(3):123-32. PubMed ID: 5553461
    [No Abstract]   [Full Text] [Related]  

  • 11. Can infarct size be limited in patients with acute myocardial infarction?
    Muller JE; Braunwald E
    Cardiovasc Clin; 1983; 13(1):147-61. PubMed ID: 6129059
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the coronary therapeutic agent STENO-Tromcardin in the general practice].
    Jaschke J
    Med Welt; 1969 Mar; 13():744-6. PubMed ID: 5784357
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect of potassium magnesium asparagine in disorders of the impulse formation and conduction system of the heart].
    Maté K; Birtalan G; Horváth J; Kövágó M
    Orv Hetil; 1967 May; 108(20):939-41. PubMed ID: 6077670
    [No Abstract]   [Full Text] [Related]  

  • 14. Bicordin--a new drug in the treatment of coronary heart disease.
    Samochowiec L; Wójcicki J; Gregorczyk K; Szmatloch E
    Mater Med Pol; 1974; 6(4):298-300. PubMed ID: 4453155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous therapy of ischemic heart diseases by Tromcardin].
    Wölke F
    Ther Ggw; 1969 Nov; 108(11):1586 passim. PubMed ID: 5379784
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].
    Pedersen A
    Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasodilator therapy in coronary artery disease. Part I.
    Hager WD
    Ariz Med; 1977 Jun; 34(6):403-4. PubMed ID: 880054
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of a combination of di-isopropylammonium dichlorethanoate (Diedi) and pentaerythrol tetranitrate (Nitrate) in the treatment of coronary disease. Clinical electrocerdiographic and coronarographic remarks].
    Tronconi L; Baldrighi G; Massoni G; Calderoni AG; Baldrighi V
    Minerva Cardioangiol; 1967 Mar; 15(3):211-7. PubMed ID: 5604123
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aponal in the therapy of organic coronary blood flow disorders].
    Emig W
    Dtsch Med J; 1970 Jun; 21(11):816-22. PubMed ID: 5512352
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of disorders of myocardial metabolism with potassium-magnesium aspartate].
    Reichertz PL; Noell G; Hemmati A
    Med Welt; 1967 Sep; 38():2236-43. PubMed ID: 5614953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.